because some serious complications were reported when a terbutaline intravenous bolus ( 0.25 mg ) was used as a tocolytic , we assessed its safety and efficacy when used in patients not affected by cardiovascular disease , tachycardia greater than 100 beats/min , thyrotoxicosis , fluid overload , corticoids , atropine , or severe abruptio placentae .
C0039231
tachycardia
C0004259
atropine